Skip to main content
Clinical Trials/NCT03469505
NCT03469505
Completed
Not Applicable

Cooperative Pain Education and Self-management: Expanding Treatment for Real-world Access (COPES ExTRA)

Yale University9 sites in 1 country764 target enrollmentDecember 27, 2019
ConditionsPain, Chronic

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pain, Chronic
Sponsor
Yale University
Enrollment
764
Locations
9
Primary Endpoint
Brief Pain Inventory, Interference Subscale Score
Status
Completed
Last Updated
11 months ago

Overview

Brief Summary

To conduct a superiority trial of COPES versus standard Veterans Health Administration (VHA) Cognitive Behavioral Therapy Chronic Pain (CBT-CP)

Detailed Description

Our prior efficacy trial found that COPES was not inferior to in-person CBT-CP and that participants attended, on average, a little over two more treatment weeks in COPES than in-person treatment, presumably due to the ease of in-home treatment attendance relative to in-person treatment.

Registry
clinicaltrials.gov
Start Date
December 27, 2019
End Date
February 20, 2025
Last Updated
11 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients with chronic musculoskeletal pain receiving care in VHA.
  • A pain-related musculoskeletal diagnosis indicated by an EHR identified ICD-9 or -10 code.
  • The presence of chronic pain of at least moderate severity with EHR NRS pain scores ≥ 4 in three separate months for a period of 12 months.
  • Absence of mental illness serious enough to have resulted in an inpatient psychiatric hospitalization in the prior 3 months excluding detoxification of alcohol or drugs.
  • Absence of malignant cancer diagnosis or receipt of hospice or end-of-life palliative care.
  • Ability to participate safely in the walking portion of the intervention as evidenced by patient-reported ability to walk at least one block and absence of diabetic foot ulcers at the time of the enrollment.
  • Absence of significant cognitive impairment as identified by a dementia-related diagnosis.
  • Availability of a touch-tone land-line or cellular telephone and no vision or hearing deficits that would impair participation verified by patient report at the time of the enrollment call.

Exclusion Criteria

  • Patients not fitting criteria for inclusion.

Outcomes

Primary Outcomes

Brief Pain Inventory, Interference Subscale Score

Time Frame: 4 months

The Brief Pain Inventory Interference Score is patient-reported pain-related interference. Data will be collected through automated IVR calls.

Secondary Outcomes

  • The Brief Pain Inventory, Interference Score(6 months, 12 months)
  • Numeric Rating Score, Pain Intensity(4 month)
  • PEG-3(4 month)
  • Depression symptom severity(4 months)
  • Pain Catastrophizing Scale- Short Form(4 months)
  • Sleep Quality(4 months)
  • Pain Satisfaction Questionnaire(4 month)
  • Treatment dose(Up to 12 months post baseline)
  • Pain Self-Efficacy(4 months)
  • Patient Global Perception of Change(4 months)

Study Sites (9)

Loading locations...

Similar Trials